Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT-288

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND ABT-288, a highly selective histamine-3 receptor antagonist, demonstrated efficacy across several preclinical… Expand
Is this relevant?
2014
2014
INTRODUCTION ABT-288 is a highly potent histamine-3 receptor antagonist that has demonstrated pro-cognitive effects in… Expand
Is this relevant?
2014
2014
AIMS ABT-288 is a potent and selective H3 receptor antagonist with procognitive effects in several preclinical models. In… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
2014
2014
  • George M. Haiga, Yili Pritchetta, +4 authors Robert Lenza
  • 2014
  • Corpus ID: 8485172
Background: ABT-288, a highly selective histamine-3 receptor antagonist, demonstrated efficacy across several preclinical… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
AIM The objective of this work was to characterize the safety, tolerability and pharmacokinetics of ABT-288, a highly selective… Expand
Is this relevant?
2013
2013
RationaleHistamine H3 receptor antagonists, such as ABT-288, have been shown to possess cognitive-enhancing and wakefulness… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Blockade of the histamine H3 receptor (H3R) enhances central neurotransmitter release, making it an attractive target for the… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?